Abacus Life(US:ABL) Prnewswireยท2025-08-16 14:00Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices by Abacus Global Management, Inc. [1] Group 1: Investigation Details - The investigation is focused on whether Abacus and its officers or directors have engaged in fraudulent activities [1] - A report by Morpheus Research alleges that Abacus has manipulated its portfolio valuation methodology to present a misleadingly profitable image [2] - The report also raises concerns about Abacus's life expectancy estimation methods and highlights historical issues related to its co-founders [2] Group 2: Market Reaction - Following the news of the investigation and the report, Abacus's stock price dropped by $1.64 per share, representing a 21.47% decline, closing at $6.00 per share on June 5, 2025 [3]